NCT04658433View on ClinicalTrials.gov

The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

December 20, 2021

Study Completion Date

February 10, 2022

Conditions
Cardiovascular Risk FactorCovid19
Interventions
DIETARY_SUPPLEMENT

300 mg of omega3-FA

The participant will receive 1,000 mg of wild salmon and fish oil complex once daily, which contains 300 mg of omega3-FA.

Trial Locations (1)

Unknown

Mahmoud S Abu-Samak, Amman

All Listed Sponsors
lead

Applied Science Private University

OTHER

NCT04658433 - The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People | Biotech Hunter | Biotech Hunter